GABRA6 and epilepsy: In conclusion, the present accumulated evidence revealed that neither the GABRA1 rs2279020 nor the GABRA6 rs3219151 polymorphism was a risk factor for the etiology of epilepsy and antiepileptic drug responsiveness in the Asian and Arabic populations.